Amicus Therapeutics Inc. buy StockNews.com
Start price
16.11.24
/
50%
€9.20
Target price
16.11.25
-
Performance (%)
-34.78%
Price
11.08.25
€5.75
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Amicus Therapeutics Inc. is performing very badly with a performance of -34.78%. This prediction currently runs until 16.11.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | -1.709% | -1.709% |
| iShares Core DAX® | 1.061% | -0.453% |
| iShares Nasdaq 100 | 2.615% | 4.747% |
| iShares Nikkei 225® | 5.693% | 9.002% |
| iShares S&P 500 | 1.433% | 3.156% |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.70
11.03.23
11.03.23
-
11.03.24
11.03.24
2.80%
12.03.24
12.03.24
